Subtype-specific β-adrenoceptor signaling pathways in the heart and their potential clinical implications

Braunwald, 2000, Congestive heart failure: fifty years of progress, Circulation, 102, 14, 10.1161/01.CIR.102.suppl_4.IV-14 Bristow, 2000, Mechanistic and clinical rationales for using β-blockers in heart failure, J. Card. Fail, 6, 8 Xiao, 2001, β-Adrenergic signaling in the heart: dual coupling of the β2-adrenergic receptor to Gs and Gi proteins, Sci. STKE, 104, RE15 Xiao, 1993, β1-adrenoceptor stimulation and β2-adrenoceptor stimulation differ in their effects on contraction, cytosolic Ca2+, and Ca2+ current in single rat ventricular cells, Circ. Res., 73, 286, 10.1161/01.RES.73.2.286 Xiao, 1994, β2-adrenergic receptor-stimulated increase in cAMP in rat heart cells is not coupled to changes in Ca2+ dynamics, contractility, or phospholamban phosphorylation, J. Biol. Chem., 269, 19151, 10.1016/S0021-9258(17)32287-1 Kuznetsov, 1995, β2-adrenergic receptor actions in neonatal and adult rat ventricular myocytes, Circ. Res., 76, 40, 10.1161/01.RES.76.1.40 Zhou, 1997, Localized cAMP-dependent signaling mediates β2-adrenergic modulation of cardiac excitation- contraction coupling, Am. J. Physiol. Heart Circ. Physiol., 273, H1611, 10.1152/ajpheart.1997.273.3.H1611 Altschuld, 1995, Response of failing canine and human heart cells to β2-adrenergic stimulation, Circulation, 92, 1612, 10.1161/01.CIR.92.6.1612 Kuschel, 1999, β2-adrenergic cAMP signaling is uncoupled from phosphorylation of cytoplasmic proteins in canine heart, Circulation, 99, 2458, 10.1161/01.CIR.99.18.2458 Kuschel, 1999, Gi protein-mediated functional compartmentalization of cardiac β2-adrenergic signaling, J. Biol. Chem., 274, 22048, 10.1074/jbc.274.31.22048 Chen-Izu, 2000, Gi-dependent localization of β2-adrenergic receptor signaling to L-type Ca2+ channels, Biophys. J., 79, 2547, 10.1016/S0006-3495(00)76495-2 Kaumann, 1996, β2-adrenoceptor activation by zinterol causes protein phosphorylation, contractile effects and relaxant effects through a cAMP pathway in human atrium, Mol. Cell. Biochem., 163-164, 113, 10.1007/BF00408647 Kaumann, 1999, Activation of β2-adrenergic receptors hastens relaxation and mediates phosphorylation of phospholamban, troponin I, and C- protein in ventricular myocardium from patients with terminal heart failure, Circulation, 99, 65, 10.1161/01.CIR.99.1.65 Xiao, 1995, Functional coupling of the β2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes, Mol. Pharmacol., 47, 322 Xiao, 1999, Coupling of β2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes, Circ. Res., 84, 43, 10.1161/01.RES.84.1.43 Kilts, 2000, β2-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both Gs and Gi, Circ. Res., 87, 705, 10.1161/01.RES.87.8.705 Xiao, 1998, Age-associated reductions in cardiac β1- and β2-adrenergic responses without changes in inhibitory G proteins or receptor kinases, J. Clin. Invest., 101, 1273, 10.1172/JCI1335 Jo, 2002, Phosphatidylinositol 3-kinase functionally compartmentalizes the concurrent Gs signaling during β2-adrenergic stimulation, Circ. Res., 91, 46, 10.1161/01.RES.0000024115.67561.54 Narula, 1996, Apoptosis in myocytes in end-stage heart failure, N. Engl. J. Med., 335, 1182, 10.1056/NEJM199610173351603 Olivetti, 1997, Apoptosis in the failing humans heart, N. Engl. J. Med., 336, 1131, 10.1056/NEJM199704173361603 Olivetti, 1996, Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart, J. Mol. Cell. Cardiol., 28, 2005, 10.1006/jmcc.1996.0193 Li, 1997, Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat, Am. J. Physiol., 272, H2313 Wencker, 2003, A mechanistic role for cardiac myocyte apoptosis in heart failure, J. Clin. Invest., 111, 1497, 10.1172/JCI17664 Communal, 1999, Opposing effects of β1- and β2-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein, Circulation, 100, 2210, 10.1161/01.CIR.100.22.2210 Zaugg, 2000, β-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes, Circulation, 102, 344, 10.1161/01.CIR.102.3.344 Rohrer, 1999, Cardiovascular and metabolic alterations in mice lacking both β1- and β2-adrenergic receptors, J. Biol. Chem., 274, 16701, 10.1074/jbc.274.24.16701 Zhou, 2000, Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology, Am. J. Physiol. Heart Circ. Physiol., 279, H429, 10.1152/ajpheart.2000.279.1.H429 Zhu, 2001, Dual modulation of cell survival and cell death by β2-adrenergic signaling in adult mouse cardiac myocytes, Proc. Natl. Acad. Sci. U. S. A., 98, 1607, 10.1073/pnas.98.4.1607 Chesley, 2000, The β2-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through Gi-dependent coupling to phosphatidylinositol 3′-kinase, Circ. Res., 87, 1172, 10.1161/01.RES.87.12.1172 Dorn, 1999, Low- and high-level transgenic expression of β2-adrenergic receptors differentially affect cardiac hypertrophy and function in Gαq-overexpressing mice, Proc. Natl. Acad. Sci. U. S. A., 96, 6400, 10.1073/pnas.96.11.6400 Liggett, 2000, Early and delayed consequences of β2-adrenergic receptor overexpression in mouse hearts: critical role for expression level, Circulation, 101, 1707, 10.1161/01.CIR.101.14.1707 Milano, 1994, Enhanced myocardial function in transgenic mice overexpressing the β2-adrenergic receptor, Science, 264, 582, 10.1126/science.8160017 Engelhardt, 1999, Progressive hypertrophy and heart failure in β1-adrenergic receptor transgenic mice, Proc. Natl. Acad. Sci. U. S. A., 96, 7059, 10.1073/pnas.96.12.7059 Bisognano, 2000, Myocardial-directed overexpression of the human β1-adrenergic receptor in transgenic mice, J. Mol. Cell. Cardiol., 32, 817, 10.1006/jmcc.2000.1123 Iwase, 1996, Adverse effects of chronic endogenous sympathetic drive induced by cardiac Gsα overexpression, Circ. Res., 78, 517, 10.1161/01.RES.78.4.517 Patterson, 2004, Protecting the myocardium: a role for the β2-adrenergic receptor in the heart, Crit. Care Med., 32, 1041, 10.1097/01.CCM.0000120049.43113.90 Daaka, 1997, Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A, Nature, 390, 88, 10.1038/36362 Shizukuda, 2002, Subtype specific roles of β-adrenergic receptors in apoptosis of adult rat ventricular myocytes, J. Mol. Cell. Cardiol., 34, 823, 10.1006/jmcc.2002.2020 Communal, 2000, p38 mitogen-activated protein kinase pathway protects adult rat ventricular myocytes against β-adrenergic receptor-stimulated apoptosis. Evidence for Gi-dependent activation, J. Biol. Chem., 275, 19395, 10.1074/jbc.M910471199 Tepe, 1999, Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: enhanced basal catalytic activity and function without increased cardiomyocyte β-adrenergic signaling, Biochemistry, 38, 16706, 10.1021/bi991619k Gao, 1999, Adenylyl cyclase increases responsiveness to catecholamine stimulation in transgenic mice, Circulation, 99, 1618, 10.1161/01.CIR.99.12.1618 Zhu, 2003, Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/Calmodulin Kinase II, J. Clin. Invest., 111, 617, 10.1172/JCI200316326 Zhang, 2003, The δC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure, Circ. Res., 92, 912, 10.1161/01.RES.0000069686.31472.C5 Yatani, 1989, Rapid β-adrenergic modulation of cardiac calcium channel currents by a fast G protein pathway, Science, 245, 71, 10.1126/science.2544999 Lader, 1998, Cardiac Gsα overexpression enhances L-type calcium channels through an adenylyl cyclase independent pathway, Proc. Natl. Acad. Sci. U. S. A., 95, 9669, 10.1073/pnas.95.16.9669 Schafer, 2000, Hypertrophic effect of selective β1-adrenoceptor stimulation on ventricular cardiomyocytes from adult rat, Am. J. Physiol. Cell Physiol., 279, C495, 10.1152/ajpcell.2000.279.2.C495 Morisco, 2001, β-adrenergic cardiac hypertrophy is mediated primarily by the β1-subtype in the rat heart, J. Mol. Cell. Cardiol., 33, 561, 10.1006/jmcc.2000.1332 Morisco, 2000, The Akt-glycogen synthase kinase 3β pathway regulates transcription of atrial natriuretic factor induced by beta-adrenergic receptor stimulation in cardiac myocytes, J. Biol. Chem., 275, 14466, 10.1074/jbc.275.19.14466 Ramirez, 1997, The nuclear δB isoform of Ca2+/calmodulin-dependent protein kinase II regulates atrial natriuretic factor gene expression in ventricular myocytes, J. Biol. Chem., 272, 31203, 10.1074/jbc.272.49.31203 Colomer, 2000, Chronic elevation of calmodulin in the ventricles of transgenic mice increases the autonomous activity of calmodulin-dependent protein kinase II, which regulates atrial natriuretic factor gene expression, Mol. Endocrinol., 14, 1125, 10.1210/me.14.8.1125 Mason, 1999, A Gain-of-function polymorphism in a G-protein coupling domain of the human β1-adrenergic receptor, J. Biol. Chem., 274, 12670, 10.1074/jbc.274.18.12670 Iwai, 2003, Arg389Gly polymorphism of the human β1-adrenergic receptor in patients with nonfatal acute myocardial infarction, Am. Heart J., 146, 106, 10.1016/S0002-8703(03)00110-8 Wagoner, 2002, Polymorphisms of the β1-adrenergic receptor predict exercise capacity in heart failure, Am. Heart J., 144, 840, 10.1067/mhj.2002.125325 Small, 2002, Synergistic polymorphisms of β1- and α2C-adrenergic receptors and the risk of congestive heart failure, New Engl. J. Med., 347, 1135, 10.1056/NEJMoa020803 Liggett, 1998, The Ile164 β2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure, J. Clin. Invest., 102, 1534, 10.1172/JCI4059 Maack, 2001, Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure, J. Am. Coll. Cardiol., 38, 939, 10.1016/S0735-1097(01)01471-1 Metra, 2000, Differential effects of β-blockers in patients with heart failure: a prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol, Circulation, 102, 546, 10.1161/01.CIR.102.5.546 Poole-Wilson, 2003, Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial, Lancet, 362, 7, 10.1016/S0140-6736(03)13800-7 Hall, 1990, Selective β1-adrenoceptor blockade enhances positive inotropic responses to endogenous catecholamines mediated through β2-adrenoceptors in human atrial myocardium, Circ. Res., 66, 1610, 10.1161/01.RES.66.6.1610 Hall, 1991, In vivo demonstration of cardiac β2-adrenoreceptor sensitization by β1-antagonist treatment, Circ. Res., 69, 959, 10.1161/01.RES.69.4.959 Ping, 1995, Reduced β-adrenergic receptor activation decreases G-protein expression and β-adrenergic receptor kinase activity in porcine heart, J. Clin. Invest., 95, 1271, 10.1172/JCI117777 Iaccarino, 1998, Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by β-adrenergic receptor stimulation and blockade, Circulation, 98, 1783, 10.1161/01.CIR.98.17.1783 Koch, 1995, Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor, Science, 268, 1350, 10.1126/science.7761854 Rockman, 1998, Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice, Proc. Natl. Acad. Sci. U. S. A., 95, 7000, 10.1073/pnas.95.12.7000 Harding, 2001, Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure, Proc. Natl. Acad. Sci. U. S. A., 98, 5809, 10.1073/pnas.091102398 Eschenhagen, 1992, Increased messenger RNA level of the inhibitory G protein alpha subunit Giα1 in human end-stage heart failure, Circ. Res., 70, 688, 10.1161/01.RES.70.4.688 Bohm, 1994, Radioimmunochemical quantification of Giα in right and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure, J. Mol. Cell. Cardiol., 26, 133, 10.1006/jmcc.1994.1017 Bristow, 1986, β1- and β2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective β1-receptor down-regulation in heart failure, Circ. Res., 59, 297, 10.1161/01.RES.59.3.297 Kiuchi, 1993, Myocardial β-adrenergic receptor function during the development of pacing-induced heart failure, J. Clin. Invest., 91, 907, 10.1172/JCI116312 Xiao, 2003, Enhanced Gi signaling mediates the diminution of β2-adrenergic contractile response in failing spontaneous hypertensive rat heart, Circulation, 108, 1633, 10.1161/01.CIR.0000087595.17277.73 Kompa, 1999, Desensitization of cardiac β-adrenoceptor signaling with heart failure produced by myocardial infarction in the rat. Evidence for the role of Gi but not Gs or phosphorylating proteins, J. Mol. Cell. Cardiol., 31, 1185, 10.1006/jmcc.1999.0951 Brown, 1992, The effect of pertussis toxin on β-adrenoceptor responses in isolated cardiac myocytes from noradrenaline-treated guinea-pigs and patients with cardiac failure, Br. J. Pharmacol., 106, 115, 10.1111/j.1476-5381.1992.tb14302.x Rau, 2003, Overexpression of wild-type Gαi-2 suppresses β-adrenergic signaling in cardiac myocytes, FASEB J., 17, 523, 10.1096/fj.02-0660fje Ranu, 2000, Gi-dependent suppression of β1-adrenoceptor effects in ventricular myocytes from NE-treated guinea pigs, Am. J. Physiol. Heart Circ. Physiol., 278, H1807, 10.1152/ajpheart.2000.278.6.H1807 Kenakin, 1995, Agonist-receptor efficacy. II. Agonist trafficking of receptor signals, Trends Pharmacol. Sci., 16, 232, 10.1016/S0165-6147(00)89032-X Ahmet, 2002, Chronic treatment with β2-adrenergic (AR) agonist, fenoterol, arrests the functional decline following myocardial infarction in rats, J. Card. Fail., 8, S9 Gong, 2002, Specific β2AR blocker ICI 118,551 actively decreases contraction through a Gi-coupled form of the β2AR in myocytes from failing human heart, Circulation, 105, 2497, 10.1161/01.CIR.0000017187.61348.95 Sato, 2004, Loss of β-adrenoceptor response in myocytes overexpressing the Na+/Ca2+-exchanger, J. Mol. Cell. Cardiol., 36, 45, 10.1016/j.yjmcc.2003.09.010 Studer, 1994, Gene expression of the cardiac Na+–Ca2+ exchanger in end-stage human heart failure, Circ. Res., 75, 443, 10.1161/01.RES.75.3.443 Nienaber, 2003, Inhibition of receptor-localized PI3K preserves cardiac β-adrenergic receptor function and ameliorates pressure overload heart failure, J. Clin. Invest., 112, 1067, 10.1172/JCI18213